🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/11/2014 56,98 57,20 56,50 56,65 +0,95% 1,24% 13.942.173
10/11/2014 55,57 56,48 55,06 56,12 -0,89% 2,56% 15.299.228
07/11/2014 56,67 56,89 56,36 56,62 +0,13% 0,94% 11.122.424
06/11/2014 56,87 57,16 56,48 56,55 -0,52% 1,19% 14.003.481
05/11/2014 57,24 57,49 56,66 56,84 +0,34% 1,45% 13.287.382
04/11/2014 56,17 56,98 56,17 56,65 +0,76% 1,43% 11.882.643
03/11/2014 55,30 56,23 54,93 56,22 +1,69% 2,35% 10.667.487
31/10/2014 55,30 55,47 55,02 55,29 +1,10% 0,81% 14.741.273
30/10/2014 53,16 54,76 53,15 54,69 +1,97% 3,03% 13.484.197
29/10/2014 53,45 54,02 53,08 53,63 +0,63% 1,75% 13.092.559
28/10/2014 54,01 54,01 51,62 53,29 -1,06% 4,42% 25.111.338
27/10/2014 54,30 54,62 53,36 53,86 -2,01% 2,32% 15.111.007
24/10/2014 54,20 55,02 54,04 54,97 +1,73% 1,81% 8.966.059
23/10/2014 53,68 54,46 53,62 54,04 +2,02% 1,56% 12.419.953
22/10/2014 52,70 53,30 52,48 52,97 +0,69% 1,56% 13.520.982
21/10/2014 52,07 52,75 51,83 52,61 +2,00% 1,76% 18.119.815
20/10/2014 51,74 51,78 51,45 51,57 +0,06% 0,65% 12.643.177
17/10/2014 51,38 52,13 51,08 51,55 +1,10% 2,04% 20.664.569
16/10/2014 51,54 51,61 50,09 50,98 -2,38% 2,96% 22.905.298
15/10/2014 52,83 53,31 51,80 52,22 -2,84% 2,85% 19.687.518
14/10/2014 53,98 54,34 53,18 53,75 +0,34% 2,16% 11.460.718
13/10/2014 55,87 55,87 53,42 53,57 -4,30% 4,39% 15.518.470
10/10/2014 56,59 57,18 55,97 55,97 -0,93% 2,12% 11.826.890
09/10/2014 57,25 57,74 56,40 56,50 -1,61% 2,33% 9.008.398
08/10/2014 55,97 57,47 55,89 57,42 +2,94% 2,83% 12.909.474
07/10/2014 56,60 56,68 55,77 55,78 -1,88% 1,60% 9.977.065
06/10/2014 57,41 57,49 56,58 56,85 -0,53% 1,58% 7.456.101
03/10/2014 56,46 57,35 56,46 57,16 +1,78% 1,57% 9.056.606
02/10/2014 56,09 56,36 55,62 56,15 +0,24% 1,31% 8.499.070
01/10/2014 56,38 56,51 55,82 56,02 -0,96% 1,22% 9.525.167